|
Exhibit 4.2
THE SECURITIES REPRESENTED HEREBY HAVE NOT BE
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY
STATE SECURITIES LAWS AND NEITHER THE SECURITIES NOR ANY INTEREST
THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE
DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION UNDER SUCH
ACT OR AN EXEMPTION FROM REGISTRATION, WHICH IN THE OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THIS CORPORATION, IS AVAILABLE.
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS
EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN
SECTION 4 OF THIS WARRANT
|
Warrant No. [____]
|
Number of Shares: [________]
|
|
|
(subject to adjustment)
|
|
Date of Issuance: [___________], 2008
|
|
|
Original Issue Date (as defined in subsection 2(a)):
[___________], 2008
|
|
NovaDel Pharma Inc.
Common Stock Purchase Warrant
(Void after [_________], 2013)
NovaDel Pharma Inc., a Delaware corporation (the
“Company”), for value received, hereby certifies that
[_________], or its registered assigns (the “Registered
Holder”), is entitled, subject to the terms and conditions
set forth below, to purchase from the Company, at any time or from
time to time on or after the six month anniversary after the date
of issuance and on or before 5:00 p.m. (Eastern time) on
[___________], 2013 (the “Exercise Period”), up to
[________] shares of Common Stock, $0.001 par value per share, of
the Company (“Common Stock”), at a purchase price of $[
] per share. The shares purchasable upon exercise of this Warrant,
and the purchase price per share, each as adjusted from time to
time pursuant to the provisions of this Warrant, are hereinafter
referred to as the “Warrant Shares” and the
“Purchase Price,” respectively.
(a)
Exercise for Cash . The
Registered Holder may, at its option, elect to exercise this
Warrant, in whole or in part and at any time or from time to time
during the Exercise Period, by surrendering this Warrant, with the
purchase form appended hereto as Exhibit I duly executed by or on behalf of
the Registered Holder, at the principal office of the Company, or
at such other office or agency as the Company may designate,
accompanied by payment in full, in lawful money of the United
States, of the Purchase Price payable in respect of the number of
Warrant Shares purchased upon such exercise. A facsimile signature
of the Registered Holder on the purchase form shall be sufficient
for purposes of exercising this
Warrant, provided that the Company receives the
Registered Holder’s original signature within three (3)
business days thereafter.
(i) At any time
during the Exercise Period when the resale of the Warrant Shares by
the Registered Holder is not registered pursuant to an effective
registration statement filed with the Securities and Exchange
Commission under the Securities Act of 1933, as amended (the
“Securities Act”), the Registered Holder may, at its
option, elect to exercise this Warrant, in whole or in part, on a
cashless basis, by surrendering this Warrant, with the purchase
form appended hereto as Exhibit
I duly executed by or on behalf of the
Registered Holder, at the principal office of the Company, or at
such other office or agency as the Company may designate, by
canceling a portion of this Warrant in payment of the Purchase
Price payable in respect of the number of Warrant Shares purchased
upon such exercise. In the event of an exercise pursuant to this
subsection 1(b), the number of Warrant Shares issued to the
Registered Holder shall be determined according to the following
formula:
X = Y(A-B)
|
|
Where:
|
X =
|
the number of Warrant Shares that shall be issued to
the Registered
|
|
|
Y =
|
the number of Warrant Shares for which this Warrant
is being exercised (which shall include both the number of Warrant
Shares issued to the Registered Holder and the number of Warrant
Shares subject to the portion of the Warrant being cancelled in
payment of the Purchase Price);
|
|
|
A =
|
the Fair Market Value (as defined below) of one
share of Common Stock; and
|
|
|
B =
|
the Purchase Price then in effect.
|
(ii) The
Fair Market Value per share of Common Stock shall be determined as
follows:
(1) If the
Common Stock is listed on a national securities exchange, the
Nasdaq Global Market, the Nasdaq Capital Market, the American Stock
Exchange or another nationally recognized trading system, including
the OTC Bulletin Board, as of the Exercise Date, the Fair Market
Value per share of Common Stock shall be deemed to be the average
of the high and low reported sale prices per share of Common Stock
thereon on the trading day immediately preceding the Exercise Date
( provided that
if no such price is reported on such day, the Fair Market Value per
share of Common Stock shall be determined pursuant to clause (2)
below).
(2) If the
Common Stock is not listed on a national securities exchange, the
Nasdaq Global Market, the Nasdaq Capital Market, the American Stock
Exchange or another nationally recognized trading system, including
the OTC Bulletin Board, as of the
Exercise Date, the Fair Market Value per share of
Common Stock shall be deemed to be the amount most recently
determined in good faith by the Board of Directors of the Company
(the “Board”) to represent the fair market value per
share of the Common Stock (including without limitation a
determination for purposes of granting Common Stock options or
issuing Common Stock under any plan, agreement or arrangement with
employees of the Company); and, upon request of the Registered
Holder, the Board (or a representative thereof) shall, as promptly
as reasonably practicable but in any event not later than 10 days
after such request, notify the Registered Holder of the Fair Market
Value per share of Common Stock and furnish the Registered Holder
with reasonable documentation of the Board’s determination of
such Fair Market Value. Notwithstanding the foregoing, if the Board
has not made such a determination within the three-month period
prior to the Exercise Date, then (A) the Board shall make, and
shall provide or cause to be provided to the Registered Holder
notice of, a determination of the Fair Market Value per share of
the Common Stock within 15 days of a request by the Registered
Holder that it do so, and (B) the exercise of this Warrant
pursuant to this subsection 1(b) shall be delayed until such
determination is made and notice thereof is provided to the
Registered Holder.
(c)
Exercise Date . Each
exercise of this Warrant shall be deemed to have been effected
immediately prior to the close of business on the day on which this
Warrant shall have been surrendered to the Company as provided in
subsection 1(a) or 1(b) above (the “Exercise Date”). At
such time, the person or persons in whose name or names any
certificates for Warrant Shares shall be issuable upon such
exercise as provided in subsection 1(d) below shall be deemed to
have become the holder or holders of record of the Warrant Shares
represented by such certificates.
(d)
Issuance of Certificates . As soon as practicable after the exercise of this Warrant in
whole or in part, and in any event within 3 trading days
thereafter, the Company, at its expense, will cause to be issued in
the name of the Registered Holder, or as the Registered Holder
(upon payment by the Registered Holder of any applicable transfer
taxes) may direct:
(i) a
certificate or certificates for the number of full Warrant Shares
to which the Registered Holder shall be entitled upon such exercise
plus, in lieu of any fractional share to which the Registered
Holder would otherwise be entitled, cash in an amount determined
pursuant to Section 3 hereof or at the written request of the
Registered Holder, the Company shall cause certificates for Warrant
Shares purchased hereunder to be transmitted by the transfer agent
of the Company to the Registered Holder by crediting the account of
the Registered Holder’s prime broker with the Depository
Trust Company through its Deposit Withdrawal Agent Commission
system if the Company is a participant in such system;
and
(ii) in
case such exercise is in part only, a new warrant or warrants
(dated the date hereof) of like tenor, calling in the aggregate on
the face or faces thereof for the number of Warrant Shares equal
(without giving effect to any adjustment therein) to the number of
such shares called for on the face of this Warrant minus the number
of Warrant Shares for which this Warrant was so exercised (which,
in the case of an exercise pursuant to subsection 1(b), shall
include both the number of Warrant Shares issued to the Registered
Holder pursuant to such partial exercise and the number of Warrant
Shares subject to the portion of the Warrant being cancelled in
payment of the Purchase Price).
(e) Notwithstanding
the foregoing, in no event shall the Registered Holder be entitled
to exercise this Warrant for a number of Warrant Shares in excess
of that number of
Warrants Shares which, upon giving effect to such
exercise, would cause the aggregate number of shares of Common
Stock beneficially owned by the Registered Holder and its
affiliates to exceed 19.99% of the total outstanding shares of the
Company’s Common Stock following such exercise. The
limitations contained in this Section 1(e) shall apply only to
the extent required under Section 713(b) of the American Stock
Exchange Company Guide. Notwithstanding the limitations set forth
in this Section 1(e), but subject to Section 713(b) of the
American Stock Exchange Company Guide, this Warrant shall be fully
exercisable upon a Liquidation Event (defined below). For purposes
of this Section 1(e), “Liquidation Event” shall
mean the consummation of any of the following transactions:
(a) a merger or consolidation in which the Company is not the
surviving corporation (other than a merger or consolidation with a
wholly-owned subsidiary, a reincorporation of the Company in a
different jurisdiction, or other transaction in which there is no
substantial change in the shareholders of the Company),
(b) the sale of all or substantially all of the assets of the
Company, or (c) the acquisition, sale, or transfer of more
than 50% of the outstanding shares of the Company by tender offer
or similar transaction.
(a)
Adjustment for Stock Splits and
Combinations . If the Company shall at
any time or from time to time after the date on which this Warrant
was first issued (or, if this Warrant was issued upon partial
exercise of, or in replacement of, another warrant of like tenor,
then the date on which such original warrant was first issued) (the
“Original Issue Date”) effect a subdivision of the
outstanding Common Stock, the Purchase Price then in effect
immediately before that subdivision shall be proportionately
decreased. If the Company shall at any time or from time to time
after the Original Issue Date combine the outstanding shares of
Common Stock, the Purchase Price then in effect immediately before
the combination shall be proportionately increased. Any adjustment
under this paragraph shall become effective at the close of
business on the date the subdivision or combination becomes
effective.
(b)
Adjustment for Certain Dividends and
Distributions . In the event the Company
at any time, or from time to time after the Original Issue Date
shall make or issue, or fix a record date for the determination of
holders of Common Stock entitled to receive, a dividend or other
distribution payable in additional shares of Common Stock, then and
in each such event the Purchase Price then in effect immediately
before such event shall be decreased as of the time of such
issuance or, in the event such a record date shall have been fixed,
as of the close of business on such record date, by multiplying the
Purchase Price then in effect by a fraction:
(1) the
numerator of which shall be the total number of shares of Common
Stock issued and outstanding immediately prior to the
tim
|